Relationship of viral infections to wheezing illnesses and asthma

Nature Reviews Immunology

Volumn 2, Issue 2, 2002, Pages 132-138

  Gern, James E ^a   Busse, William W ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD8 ANTIGEN; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; INTERLEUKIN 8; PROTEINASE INHIBITOR;

ADULT; AIRWAY; ASTHMA; CHILD; DISEASE ASSOCIATION; DISEASE EXACERBATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RHINOVIRUS; RISK FACTOR; VIRUS INFECTION; VIRUS REPLICATION; WHEEZING; ABNORMAL RESPIRATORY SOUND;

ASTHMA; HUMANS; RESPIRATORY SOUNDS; VIRUS DISEASES; VIRUS REPLICATION;

EID: 0036482387     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri725     Document Type: Review

References (81)

1. Johnston, S. L. et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br. Med. J. 310, 1225-1229 (1995).
2. Nicholson, K. G., Kent, J. & Ireland, D. C. Respiratory viruses and exacerbations of asthma in adults. Br. Med. J. 307, 982-986 (1993).
3. Busse, W. W. & Lemanske, R. F. Jr. Asthma. N. Engl. J. Med. 344, 350-362 (2001).
4. Abu-Harb, M. et al. IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur. Respir. J. 14, 139-143 (1999).
5. Pizzichini, M. M. et al. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am. J. Respir. Crit. Care Med. 158, 1178-1184 (1998).
6. Reddel, H. et al. Differences between asthma exacerbations and poor asthma control. Lancet 353, 364-369 (1999).
7. Martinez, F. D. et al. Asthma and wheezing in the first six years of life. N. Engl. J. Med. 332, 133-138 (1995).
8. Martinez, F. D., Morgan, W. J., Wright, A. L., Holberg, C. J. & Taussig, L. M. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N. Engl. J. Med. 319, 1112-1117 (1988).
9. Hull, J., Thomson, A. & Kwiatkowski, D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55, 1023-1027 (2000).
10. Measuring childhood asthma prevalence before and after the 1997 redesign of the National Health Interview Survey - United States. Morbidity Mortality Weekly Rep. 49, 908-911 (2000).
11. Shay, D. K. et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. J. Am. Med. Assoc. 282, 1440-1446 (1999).
12. Castro-Rodriguez, J. A., Holberg, C. J., Wright, A. L. & Martinez, F. D. A clinical index to define risk of asthma in young children with recurrent wheezing. Am. J. Respir. Crit. Care Med. 162, 1403-1406 (2000).
13. Clough, J. B. et al. Can we predict which wheezy infants will continue to wheeze? Am. J. Respir. Crit. Care Med. 160, 1473-1480 (1999).
14. Reijonen, T. M., Kotaniemi-Syrjanen, A., Korhonen, K. & Korppi, M. Predictors of asthma three years after hospital admission for wheezing in infancy. Pediatrics 106, 1406-1412 (2000).
15. Ehlenfield, D. R., Cameron, K. & Welliver, R. C. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics 105, 79-83 (2000).
16. Koller, D. Y. et al. High levels of eosinophilic cationic protein in wheezing infants predict the development of asthma. J. Allergy Clin. Immunol. 99, 752-756 (1997).
17. Reijonen, T. M. et al. Nasopharyngel eosinophil cationic protein in bronchiolitis - relation to viral findings and subsequent wheezing. Pediatr. Pulmonol. 24, 35-41 (1997).
18. H-2 response is associated with early wheezing in infants after bronchiolitis. J. Pediatr. 130, 584-593 (1997).
19. Bont, L. et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am. J. Respir. Crit. Care Med. 161, 1518-1523 (2000).
20. Sorkness, R. L., Castleman, W. L., Kumar, A., Kaplan, M. R. & Lemanske, R. F. Jr. Prevention of chronic postbronchiolitis airway sequelae with IFN-γ treatment in rats. Am. J. Respir. Crit. Care Med. 160, 705-710 (1999).
21. Stein, R. T. et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354, 541-545 (1999).
22. Sigurs, N., Bjarnason, R., Sigurbergsson, F. & Kjellman, B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161, 1501-1507 (2000).
23. Strachan, D. P. Hay fever, hygiene, and household size, Br. Med. J. 299, 1259-1260 (1989).
24. von Mutius, E. The environmental predictors of allergic disease. J. Allergy Clin. Immunol. 105, 9-19 (2000).
25. Prescott, S. L. et al. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 353, 196-200 (1999).
26. Shaheen, S. O. et al. Measles and atopy in Guinea-Bissau. Lancet 347, 1792-1796 (1996).
27. Paunio, M. et al. Measles history and atopic diseases: a population based cross-sectional study. J. Am. Med. Assoc. 283, 343-346 (2000).
28. Ball, T. M. et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N. Engl. J. Med. 343, 538-543 (2000).
29. Matricardi, P. M. et al. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. Br. Med. J. 320, 412-417 (2000).
30. Von Ehrenstein, O. S. et al. Reduced risk of hay fever and asthma among children of farmers. Clin. Exp. Allergy 30, 187-193 (2000).
31. Gereda, J. E., Leung, D. Y. & Liu, A. H. Levels of environmental endotoxin and prevalence of atopic disease. J. Am. Med. Assoc. 264, 1652-1663 (2000).
32. von Mutius, E. et al. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin. Exp. Allergy 30, 1230-1234 (2000).
33. Riedler, J. et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 358, 1129-1133 (2001).
34. Atmar, R. L. et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch. Int. Med. 158, 2453-2459 (1998).
35. Johnston, S. L. et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time trend analysis. Am. J. Respir. Crit. Care Med. 154, 654-660 (1996).
36. McFadden, E. R. Jr et al. Thermal mapping of the airways in humans. J. Appl. Physiol. 58, 564-570 (1985).
37. Schroth, M. K. et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 20, 1220-1228 (1999).
38. Gern, J. E., Galagan, D. M., Jarjour, N. N., Dick, E. C. & Busse, W. W. Detection of rhinovirus RNA in lower airway cells during experimentally-induced infection. Am. J. Respir. Crit. Care Med. 155, 1159-1161 (1997).
39. Papadopoulos, N. G. et al. Rhinoviruses infect the lower airways. J. Infect. Dis. 181, 1875-1884 (2000).
40. Jarjour, N. N. et al. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J. Allergy Clin. Immunol. 105, 1169-1177 (2000).
41. Fraenkel, D. J. et al. Lower airway inflammation during rhinovirus colds in normal and in asthmatic subjects. Am. J. Respir. Crit. Care Med. 151, 879-886 (1995).
42. Grunberg, K. et al. Rhinovirus-induced airway inflammation in asthma. Effect of treatment with inhaled corticosteroids before and during experimental infection. Am. J. Respir. Crit. Care Med. 164, 1816-1822 (2001).
43. Grünberg, K. et al. Experimental rhinovirus 16 infection increases intercellular adhesion molecule-1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment. Clin. Exp. Allergy 30, 1015-1023 (2000).
44. Calhoun, W. J., Dick, E. C., Schwartz, L. B. & Busse, W. W. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J. Clin. Invest. 94, 2200-2208 (1994).
45. Lemanske, R. F., Jr, Dick, E. C., Swenson, C. A., Vrtis, R. F. & Busse, W. W. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J. Clin. Invest. 83, 1-10 (1989).
46. Gern, J. E., Calhoun, W. J., Swenson, C., Shen, G. & Busse, W. W. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am. J. Respir. Crit. Care Med. 155, 1872-1876 (1997).
47. Rakes, G. P. et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am. J. Respir. Crit. Care Med. 159, 785-790 (1999).
48. Arruda, E. et al. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J. Infect. Dis. 171, 1329-1333 (1995).
49. Hendley, J. O. The host response, not the virus, causes the symptoms of the common cold. Clin. Infect. Dis. 26, 847-848 (1998).
50. Kurt-Jones, E. A. et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nature Immunol. 1, 398-401 (2000).
51. Zhu, Z. et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor κ B-dependent transcriptional activation J. Clin. Invest. 97, 421-430 (1996).
52. Sanders, S. P., Siekierski, E. S., Porter, J. D., Richards, S. M. & Proud, D. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J. Virol. 72, 934-942 (1998).
53. Kaul, P., Biagioli, M. C., Singh, I. & Turner, R. B. Rhinovirus-induced oxidative stress and interleukin-8 elaboration involves p47-phox but is independent of attachment to intercellular adhesion molecule-1 and viral replication. J. Infect. Dis. 181, 1885-1890 (2000).
54. Casola, A. et al. Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus. Role in viral-induced interferon regulatory factor activation. J. Biol. Chem. 276, 19715-19722 (2001).
55. Williams, B. R. G. PKR: a sentinel kinase for cellular stress. Oncogene 18, 6112-6120 (1999).
56. Uetani, K. et al. Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase. J. Immunol. 165, 988-996 (2000).
57. Sanders, S. P. et al. Rhinovirus infection induces expression of type 2 nitric oxide synthase in human respiratory epithelial cells in vitro and in vivo. J. Allergy Clin. Immunol. 107, 235-243 (2001).
58. Terenzi, F. et al. The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors. Nucleic Acids Res. 27, 4369-4375 (1999)
59. Parry, D. E. et al. Rhinovirus-induced peripheral blood mononuclear cell responses and outcome of experimental infection in allergic subjects. J. Allergy Clin. Immunol. 105, 692-698 (2000).
60. Gern, J. E. et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J. Immunol. 156, 621-627 (1996).
61. Johnston, S. L., Papi, A., Monick, M. M. & Hunninghake, G. W. Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. J. Infect. Dis. 175, 323-329 (1997).
62. Levandowski, R. A. & Horohov, D. W. Rhinovirus induces natural killer-like cytotoxic cells and interferon alpha in mononuclear leukocytes. J. Med. Virol. 35, 116-120 (1991).
63. Stevenson, E. C. et al. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin. Exp. Allergy 27, 1027-1035 (1997).
64. Krawiec, M. E. et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. Am. J. Respir. Crit. Care Med. 163, 1338-1343 (2001).
65. Gern, J. E., Vrtis, R., Grindle, K. A., Swenson, C. & Busse, W. W. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am. J. Respir. Crit. Care Med. 162, 2226-2231 (2000).
66. Turner, R. B. Weingand, K. W., Yeh, C. H. & Leedy, D. W. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin. Infect. Dis. 26, 840-846 (1998).
67. Grünberg, K. et al. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin. Exp. Allergy 27, 36-45 (1997).
68. Cardell, L. O., Agusti, C., Takeyama, K., Stjarne, P. & Nadel, J. A. LTB(4)-induced nasal gland serous cell secretion mediated by neutrophil elastase. Am. J. Respir. Crit. Care Med. 160, 411-414 (1999).
69. Sur, S. et al. Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes. J. Leuk. Biol. 63, 715-722 (1998).
70. Garofalo, R., Kimpen, J. L. L., Welliver, R. C. & Ogra, P. L. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr. 120, 28-32 (1992).
71. Grünberg, K. et al. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am. J. Respir. Crit. Care Med. 156, 609-616 (1997).
72. Malcolm, E., Arruda, E., Hayden, E. G. & Kaiser, L. Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages. J. Clin. Virol. 21, 9-16 (2001)
73. Kaiser, L., Fritz, R. S., Straus, S. E., Gubareva, L. & Hayden, F. G. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J. Med Virol. 64, 262-268 (2001).
74. Meissner, H. C. et al. Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease. Antimicrob. Agents Chemother. 43, 1183-1188 (1999).
75. Treanor, J. J. et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. J. Am. Med. Assoc. 283, 1016-1024 (2000).
76. Hayden, F. G. et al. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N. Engl. J. Med. 343, 1282-1289 (2000).
77. Rotbart, H. A. Pleconaril treatment of enterovirus and rhinovirus infections. Infect. Med. 17, 488-490 (2000).
78. Huguenel, E. D. et al. Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1. Am. J. Respir. Crit. Care Med. 155, 1206-1210 (1997).
79. Dragovich, P. S. et al. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors, 3. Structure-activity studies of ketomethylene-containing peptidomimetics. J. Med. Chem. 42, 1203-1212 (1999).
80. Brunette, M. G., Lands, L. & Thibodeau, L. P. Childhood asthma: prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infections. Pediatrics 81, 624-629 (1988).
81. Weiss, S. T. Association studies in asthma genetics. Am. J. Respir. Crit Care Med. 164, 2014-2015 (2001).